Carcinoma ex pleomorphic adenoma

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Hazard-Bot (talk | contribs) at 11:57, 7 March 2016 (Bot: Adding {{Research help|Med}}; please leave feedback/comments at Wikipedia talk:Research help #ResHelp). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Carcinoma ex pleomorphic adenoma

Carcinoma ex pleomorphic adenoma, abbreviated ca ex PA, is a type of cancer typically found in the parotid gland. It arises from the benign tumour pleomorphic adenoma.

Its prognosis depends on the stage. Early tumour have essentially a benign behaviour.[1]

Signs and symptoms

The signs and symptoms are similar to other malignant salivary gland tumours; however, it may have been preceded by an appreciable mass that was long-standing and did not appear to be growing.

Findings that suggest a malignant salivary gland tumour include rapid growth, facial weakness (due to facial nerve compression), pain, skin ulceration, fixation of the mastoid tip and parasthesias.

Diagnosis

Carcinoma ex pleomorphic adenoma is diagnosed by examining it under the microscope with consideration of the individual history.

In approximately 75% of cases ca ex PAs arise in a pleomorphic adenoma that is apparent when the tumour is excised.[2] In the other approximately 25% of cases the individual had a pleomorphic adenoma excised previously and the diagnosis is made based on (1) the presence of a carcinoma, and (2) the history of a pleomorphic adenoma at that location.

See also

References

Template:Research help

  1. ^ Di Palma, S. (Jul 2013). "Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions". Head Neck Pathol. 7 Suppl 1: S68-76. doi:10.1007/s12105-013-0454-z. PMC 3712089. PMID 23821206.
  2. ^ Antony, J.; Gopalan, V.; Smith, RA.; Lam, AK. (Mar 2012). "Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data". Head Neck Pathol. 6 (1): 1–9. doi:10.1007/s12105-011-0281-z. PMC 3311945. PMID 21744105.